{
    "analytics_identifier":  null,
    "base_path":  "/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
    "content_id":  "d3fe78e6-f1f5-48ff-acc9-5148331aa132",
    "description":  "Pharmacovigilance system requirements",
    "details":  {
                    "attachments":  [
                                        {
                                            "accessible":  false,
                                            "alternative_format_contact_email":  "webupdates@mhra.gov.uk",
                                            "attachment_type":  "file",
                                            "content_type":  "application/pdf",
                                            "file_size":  98092,
                                            "filename":  "Overview_of_managing_updates.pdf",
                                            "id":  "8398137",
                                            "number_of_pages":  1,
                                            "title":  "Overview of managing updates",
                                            "url":  "https://assets.publishing.service.gov.uk/media/60182e5fd3bf7f70c4310a47/Overview_of_managing_updates.pdf"
                                        },
                                        {
                                            "accessible":  false,
                                            "alternative_format_contact_email":  "webupdates@mhra.gov.uk",
                                            "attachment_type":  "file",
                                            "content_type":  "application/pdf",
                                            "file_size":  12577,
                                            "filename":  "Submission_Timeframes_Overview_v6.pdf",
                                            "id":  "8398138",
                                            "number_of_pages":  1,
                                            "title":  "Submission timeframe overview",
                                            "url":  "https://assets.publishing.service.gov.uk/media/60182e3a8fa8f53fc4aee8a4/Submission_Timeframes_Overview_v6.pdf"
                                        },
                                        {
                                            "accessible":  false,
                                            "alternative_format_contact_email":  "webupdates@mhra.gov.uk",
                                            "attachment_type":  "file",
                                            "content_type":  "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
                                            "file_size":  21723,
                                            "filename":  "sPS-Update-Notification-form.xlsx",
                                            "id":  "8398139",
                                            "title":  "sPS Update Notification Form",
                                            "url":  "https://assets.publishing.service.gov.uk/media/65562c61046ed4000d8b9a51/sPS-Update-Notification-form.xlsx"
                                        }
                                    ],
                    "body":  "\u003cdiv class=\"govspeak\"\u003e\u003ch2 id=\"overview\"\u003e1. Overview\u003c/h2\u003e\n\n\u003cp\u003eThe following legal obligations apply to holders of UK marketing authorisations (MA). These include products authorised as both Category 1 and Category 2 and those authorised as a PLNI or a PLGB licence.\u003c/p\u003e\n\n\u003cp\u003e· To operate a pharmacovigilance system for UK authorised products\n· To have an appropriately qualified person responsible for pharmacovigilance (\u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e) that resides and operates anywhere in the UK or in the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e and is responsible for the establishment and maintenance of the pharmacovigilance system for UK authorised products\n· To maintain and make available upon request a pharmacovigilance system master file (\u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e) that describes the pharmacovigilance system for UK authorised products. The \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e must be accessible electronically from the UK at the same site at which reports of suspected adverse reactions may be accessed\u003c/p\u003e\n\n\u003ch2 id=\"guidance-on-the-qppv-for-uk-authorised-products\"\u003e2. Guidance on the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e for UK authorised products\u003c/h2\u003e\n\n\u003cp\u003eFor all UK \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e, the marketing authorisation holder (\u003cabbr title=\"marketing authorisation holder\"\u003eMAH\u003c/abbr\u003e) must have permanently and continuously at its disposal a \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e who resides and operates anywhere in the UK or in the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e, and is responsible for the establishment and maintenance of the pharmacovigilance system (“the UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e”). Where the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e is not in the UK, there will be a need for a national contact person for pharmacovigilance as set out below.\u003c/p\u003e\n\n\u003cp\u003eThis is provided for by regulation 182 of the Human Medicines Regulations 2012 (\u003cabbr title=\"The Human Medicines Regulations\"\u003eHMR\u003c/abbr\u003e).\u003c/p\u003e\n\n\u003cp\u003eFor Category 2 \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e, the legal requirements concerning the qualifications and responsibilities of the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e that are outlined in Article 10 of the Commission Implementing Regulation (\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e) No 520/2012 (IR) will remain unchanged.\u003c/p\u003e\n\n\u003cp\u003eFor Category 1 \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e or any PLGBs granted by the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e, legal requirements concerning the qualifications and responsibilities of the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e are outlined in paragraph 10 of \u003cabbr title=\"The Human Medicines Regulations\"\u003eHMR\u003c/abbr\u003e Schedule 12A (inserted by the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit Regulations 2019), which mirrors Article 10 of CIR.\u003c/p\u003e\n\n\u003cp\u003eStatutory guidance concerning the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e for UK authorised products is described in the Good Pharmacovigilance Practices (\u003cabbr title=\"Good Pharmacovigilance Practice\"\u003eGVP\u003c/abbr\u003e) Module I. This guidance is supplemented by the \u003ca href=\"https://www.gov.uk/government/publications/exceptions-and-modifications-to-the-eu-guidance-on-good-pharmacovigilance-practices-that-will-apply-to-uk-mahs-and-the-mhra\" class=\"govuk-link\"\u003eExceptions and modifications to the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e guidance on good pharmacovigilance practices that apply to UK marketing authorisation holders\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eThere is no temporary exemption as to the requirement to have a \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e who resides and operates in the UK or the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e and is responsible for the pharmacovigilance system for UK authorised products.\u003c/p\u003e\n\n\u003ch3 id=\"national-contact-person-for-pharmacovigilance\"\u003e2.1 National contact person for pharmacovigilance\u003c/h3\u003e\n\n\u003cp\u003eIf you choose to establish a \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e who resides and operates in the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e, you must nominate a national contact person for pharmacovigilance who resides and operates in the UK and reports to the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e. This individual should have access to the reports of suspected adverse reactions referred to in regulation 187 of the HMRs and the \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e for UK authorised products. The individual should be able to facilitate responses to pharmacovigilance queries raised by the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e, including via inspections.\u003c/p\u003e\n\n\u003cp\u003eOnce the national contact person for pharmacovigilance has been appointed, their details should be notified to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e via the \u003ca rel=\"external\" href=\"https://mhrabpm.appiancloud.com/suite/\" class=\"govuk-link\"\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e Submissions Portal\u003c/a\u003e. You should follow the instructions for submitting these details. You should receive a confirmation by email immediately upon completion of the form.\u003c/p\u003e\n\n\u003cp\u003eThere is no requirement to appoint a deputy for the UK national contact person for pharmacovigilance, but for periods of extended absence greater than one month (such as maternity leave, long-term sick leave, etc.), it is expected that another individual is assigned as the national contact person for pharmacovigilance and their details should be notified to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e within two weeks of the change. In practice, this means editing the existing details of the national contact person for pharmacovigilance that are saved in the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e Submissions portal.\u003c/p\u003e\n\n\u003ch2 id=\"guidance-on-the-psmf-for-uk-authorised-products\"\u003e3. Guidance on the \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e for UK authorised products\u003c/h2\u003e\n\n\u003cp\u003eFor all UK \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e, the \u003cabbr title=\"marketing authorisation holder\"\u003eMAH\u003c/abbr\u003e must maintain, and make available upon request of the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e, a \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e that describes the pharmacovigilance system for UK authorised products (‘the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e’).\u003c/p\u003e\n\n\u003ch3 id=\"psmf-accessibility-in-the-uk\"\u003e3.1 \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e accessibility in the UK\u003c/h3\u003e\n\n\u003cp\u003eAll UK \u003cabbr title=\"pharmacovigilance system master files\"\u003ePSMFs\u003c/abbr\u003e must be accessible electronically at the same point in the UK from which the reports of suspected adverse reactions referred to in regulation 187 of the HMRs are accessible.\u003c/p\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e needs to be permanently and immediately available for inspection at the stated location in the UK. The content within the \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e must be up to date as of the point it is requested by the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003ch3 id=\"psmf-format-content-and-representation-of-pharmacovigilance-systems\"\u003e3.2 \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e format, content and representation of pharmacovigilance systems\u003c/h3\u003e\n\n\u003cp\u003eFor Category 2 \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e or PLNIs, the legal requirements concerning the format and content of the \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e that are outlined in Chapter I of IR will remain unchanged.\u003c/p\u003e\n\n\u003cp\u003eFor Category 1 \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e or those which the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e grant as PLGBs , legal requirements concerning the format and content of the \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e are outlined in Part 1 of Schedule 12A of \u003cabbr title=\"The Human Medicines Regulations\"\u003eHMR\u003c/abbr\u003e, which mirrors Chapter I of IR.\u003c/p\u003e\n\n\u003cp\u003eAs the legal requirements concerning \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e format and content are identical for all UK \u003cabbr title=\"Marketing authorisations\"\u003eMAs\u003c/abbr\u003e a single UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e can be used for all UK authorised products. This is assuming that the pharmacovigilance system applied to all products is the same.\u003c/p\u003e\n\n\u003cp\u003eStatutory guidance concerning the \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e for UK authorised products is described in \u003cabbr title=\"Good Pharmacovigilance Practice\"\u003eGVP\u003c/abbr\u003e Module II. This guidance is supplemented by the \u003ca href=\"https://www.gov.uk/government/publications/exceptions-and-modifications-to-the-eu-guidance-on-good-pharmacovigilance-practices-that-will-apply-to-uk-mahs-and-the-mhra\" class=\"govuk-link\"\u003eExceptions and modifications to the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e guidance on good pharmacovigilance practices that apply to UK marketing authorisation holders\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eThe UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e must describe the global pharmacovigilance system and reflect the global availability of safety information for UK authorised products.\u003c/p\u003e\n\n\u003cp\u003eAs per \u003cabbr title=\"Good Pharmacovigilance Practice\"\u003eGVP\u003c/abbr\u003e Module II, there are different approaches to establishing a pharmacovigilance system. For example:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cabbr title=\"marketing authorisation holders\"\u003eMAHs\u003c/abbr\u003e can establish more than one pharmacovigilance system\u003c/li\u003e\n  \u003cli\u003eA pharmacovigilance system can be shared by several \u003cabbr title=\"marketing authorisation holders\"\u003eMAHs\u003c/abbr\u003e\n\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eThe UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e should be an accurate representation of the pharmacovigilance system that has been established and you must make sure that every pharmacovigilance system covering UK authorised products has been assigned a unique \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number by the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003ch3 id=\"how-to-request-a-uk-psmf-number\"\u003e3.3 How to request a UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number\u003c/h3\u003e\n\n\u003cp\u003eAll \u003cabbr title=\"pharmacovigilance system master files\"\u003ePSMFs\u003c/abbr\u003e that cover UK authorised products should be registered with the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e. You should request a unique UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number from the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e for each pharmacovigilance system that you are operating for UK authorised products. Where the pharmacovigilance system is shared by several \u003cabbr title=\"marketing authorisation holders\"\u003eMAHs\u003c/abbr\u003e, a single request for a UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number should be submitted to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e. A UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number can be requested via the \u003ca rel=\"external\" href=\"https://mhrabpm.appiancloud.com/suite/\" class=\"govuk-link\"\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e Submissions Portal\u003c/a\u003e. You should follow the online instructions for requesting a UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number and you should receive the number by email immediately upon completion of the form. The address from which the \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e can be electronically accessed must be in the UK. Your UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number will be invalidated if the address provided is not in the UK. Any submissions to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e using an invalidated UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number will not be accepted.\u003c/p\u003e\n\n\u003cp\u003eThe UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number will be sent to the UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e email address as well as the email address you nominated on the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number request form. If you have not received a confirmation email within three hours of submitting the form, please contact \u003ca href=\"mailto:submissions@mhra.gov.uk\" class=\"govuk-link\"\u003esubmissions@mhra.gov.uk\u003c/a\u003e. Please do not re-submit the form as this will cause delays in processing your request.\u003c/p\u003e\n\n\u003cp\u003eOnce a UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number is assigned to a pharmacovigilance system it should remain unchanged, irrespective of how the system may change and evolve over time. You should not request a new UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number if there are changes to the pharmacovigilance system, including a change of UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eYou do not need to update the initial information that was provided in the online form at the time of requesting your UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number (e.g. \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e telephone number, \u003cabbr title=\"marketing authorisation holders\"\u003eMAHs\u003c/abbr\u003e covered by the pharmacovigilance system, etc.). This information is solely for the purpose of generating and allocating a unique UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number at a specific point in time. You must maintain the pharmacovigilance system information for your UK licences via the submission of the appropriate variations to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e. \u003ca href=\"#notification-of-qppv-and-psmf-details-to-the-mhra-by-existing-holders-of-uk-marketing-authorisations\" class=\"govuk-link\"\u003eGuidance on this process is provided below\u003c/a\u003e.\u003c/p\u003e\n\n\u003ch2 id=\"guidance-for-applicants-for-uk-marketing-authorisations\"\u003e4. Guidance for applicants for UK marketing authorisations\u003c/h2\u003e\n\n\u003cp\u003eThe material to accompany an application for a UK marketing authorisation includes a summary of the applicant’s pharmacovigilance system (\u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e).\u003c/p\u003e\n\n\u003cp\u003eThis must include the following elements:\u003c/p\u003e\n\n\u003col\u003e\n  \u003cli\u003eproof that the applicant has at their disposal an appropriately qualified person responsible for pharmacovigilance who resides and operates in the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e or the UK\u003c/li\u003e\n  \u003cli\u003ethe country (which must be either the UK or a \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e/\u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e country) in which the appropriately qualified person resides and carries out his or her tasks\u003c/li\u003e\n  \u003cli\u003ethe contact details of the appropriately qualified person\u003c/li\u003e\n  \u003cli\u003ea statement signed by the applicant which says that they have the necessary means to fulfil the tasks and responsibilities listed in Part 11\u003c/li\u003e\n  \u003cli\u003ea reference to the location where the pharmacovigilance system master file for the medicinal product can be accessed electronically, which must be in the UK\u003c/li\u003e\n\u003c/ol\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e should also include the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number.\u003c/p\u003e\n\n\u003cp\u003eThe above is following \u003cabbr title=\"The Human Medicines Regulations\"\u003eHMR\u003c/abbr\u003e Schedule 8.\u003c/p\u003e\n\n\u003cp\u003eGuidance on the application process and on registering to make submissions via the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e Submissions Portal is available.\u003c/p\u003e\n\n\u003cp\u003eYou should use Agency Activity Reference ID: G0001 – Initial Marketing Authorisation Application and Subactivity Text: H002 – “Original Submission”.\u003c/p\u003e\n\n\u003cp\u003eInformation on the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e and \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e for UK authorised products should be entered in section 2.4.4 of the electronic application form (\u003cabbr title=\"electronic application form\"\u003eeAF\u003c/abbr\u003e). You should note the following:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eif the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e for UK authorised products resides and operates in the UK, the checkbox entitled “The above-mentioned qualified person resides and operates in the \u003cabbr title=\"European Economic Area\"\u003eEEA\u003c/abbr\u003e” can remain unchecked.\u003c/li\u003e\n  \u003cli\u003ethe UK location where the \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e can be accessed from does not need to be registered in the Article 57 database, therefore the associated checkbox can remain unchecked. For UK licence applications via mutual recognition or decentralised procedures, the UK \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e should be included in module 1.8.1 as a standalone file or alternatively under a UK subfolder.\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003ch2 id=\"notification-of-qppv-and-psmf-details-to-the-mhra-by-existing-holders-of-uk-marketing-authorisations\"\u003e5. Notification of \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e and \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e details to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e by existing holders of UK marketing authorisations\u003c/h2\u003e\n\n\u003cp\u003eThis guidance replaces the previous requirement to submit a Type IA(IN) variation and an accompanying eCTD sequence following updates to the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e and UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e information. New procedures have been designed to simplify processes to notify the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e of these types of changes. This guidance applies from 11 May 2023.\u003c/p\u003e\n\n\u003cp\u003eThe following changes to the \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e will no longer require the submission of a Type IA variation to update the \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e but can be submitted via an Update Notification:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eThe UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e details (i.e. UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e name, address and contact details)\u003c/li\u003e\n  \u003cli\u003eThe location in UK where the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e can be electronically accessed.\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eTo make these changes, a UK only \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e Update Notification, covering the affected product licences (\u003cabbr title=\"product license\"\u003ePL\u003c/abbr\u003e) under a unique pharmacovigilance system, must be submitted to the UK to register these changes. There is currently no fee for \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e Update Notifications. A Notification of Acceptance letter will be issued once finalised on our systems. \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e Update Notifications will be processed within 30 days of receipt of the notice.\u003c/p\u003e\n\n\u003ch3 id=\"how-to-make-a-sps-update-notification\"\u003e5.1 How to make a \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e Update Notification\u003c/h3\u003e\n\n\u003cp\u003eAll notifications to update the \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e are required to be submitted as an \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e Update Notification via the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e Submissions Portal immediately following implementation, this would be expected to be submitted within 14 days. The notification should be made within the following links in the portal:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eAgency Activity Reference ID G0109: Summary of Pharmacovigilance System Update Notification - UK-\u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e-\u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e\n\u003c/li\u003e\n  \u003cli\u003eSubactivity Text: H002 – “Original Submission” must be selected.\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eYou must submit your \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e Update Notifications outside of the eCTD product lifecycle, in collections of no more than 25 \u003cabbr title=\"product license\"\u003ePLs\u003c/abbr\u003e and you should submit no more than one collection in a single package.\u003c/p\u003e\n\n\u003ch3 id=\"documentation-you-need-to-supply\"\u003e5.2 Documentation you need to supply:\u003c/h3\u003e\n\n\u003cp\u003eYou must supply the following documentation for an \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e Update Notification:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eCover letter (in PDF format) detailing the changes being made.\u003c/li\u003e\n  \u003cli\u003e\n\u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e-Update-Notification-form (in Excel format). Please \u003ca rel=\"external\" href=\"https://assets.publishing.service.gov.uk/media/65562c61046ed4000d8b9a51/sPS-Update-Notification-form.xlsx\" class=\"govuk-link\"\u003edownload a copy\u003c/a\u003e and complete sections A, B and C.\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e (in PDF format) should be a single document and must include the following elements.\u003c/p\u003e\n\n\u003col\u003e\n  \u003cli\u003eproof that the applicant has at their disposal an appropriately qualified person responsible for pharmacovigilance who resides and operates in the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e or the UK\u003c/li\u003e\n  \u003cli\u003ethe country (which must be either the UK or a Member State) in which the appropriately qualified person resides and carries out his or her tasks\u003c/li\u003e\n  \u003cli\u003ethe contact details of the appropriately qualified person\u003c/li\u003e\n  \u003cli\u003ea statement signed by the applicant which says that they have the necessary means to fulfil the tasks and responsibilities listed in Part 11 of the Human Medicines Regulation 2012 as amended\u003c/li\u003e\n  \u003cli\u003ea reference to the location where the pharmacovigilance system master file for the medicinal product can be accessed electronically, which must be in the UK\u003c/li\u003e\n\u003c/ol\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e should also include the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number.\u003c/p\u003e\n\n\u003cp\u003eFailing to supply all required documentation and information may lead to a rejection of the \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e changes, which will require you to make a resubmission addressing all discrepancies.\u003c/p\u003e\n\n\u003cp\u003eA Notification of Acceptance letter will be issued when we have made the changes on our system.\u003c/p\u003e\n\n\u003cp\u003ePlease note that any eCTD sequence submitted will be discarded as it is not required as part of this process.\u003c/p\u003e\n\n\u003ch3 id=\"changes-to-the-uk-psmf-number\"\u003e5.3 Changes to the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number\u003c/h3\u003e\n\n\u003cp\u003eChanges to the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e (and associated information) for product licences (\u003cabbr title=\"product license\"\u003ePLs\u003c/abbr\u003e) made due to change of ownership may be submitted as part of the Change of Ownership (COA) dossier or may be submitted following grant of the COA application: (whether this has resulted in a change to the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number or not)\u003c/p\u003e\n\n\u003col\u003e\n  \u003cli\u003eIf you wish to submit the changes to the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number for a \u003cabbr title=\"product license\"\u003ePL\u003c/abbr\u003e as part of a COA application, a copy of the updated \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e may be included under module 1.8.1 of the COA dossier. This update should also include information regarding changes to the UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e details and UK location of the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e. Any subsequent changes to the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number or other details of the \u003cabbr title=\"summary of the applicant’s pharmacovigilance system\"\u003eSPS\u003c/abbr\u003e following grant of the COA should be notified to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e as per the guidance on this website.\u003c/li\u003e\n  \u003cli\u003eIf you wish to submit the changes to the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number (and associated information) after grant of the COA and not as part of the COA dossier, a Type IA(IN) variation should be submitted within 14 days after the change of ownership has been granted.\u003c/li\u003e\n\u003c/ol\u003e\n\n\u003cp\u003eChanges to the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number (and associated information) for product licenses (\u003cabbr title=\"product license\"\u003ePLs\u003c/abbr\u003e) made for any other reason, are still required to be submitted via a Type IA(IN) variation within 14 days of the change taking effect.\u003c/p\u003e\n\n\u003ch2 id=\"notification-of-qppv-and-psmf-details-to-xevmpd\"\u003e6. Notification of \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e and \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e details to \u003cabbr title=\"eXtended Eudravigilance Medicinal Product Dictionary\"\u003eXEVMPD\u003c/abbr\u003e\n\u003c/h2\u003e\n\n\u003cp\u003eFrom 1 January 2021, for Category 2 products and PLNIs, in addition to notifying the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e and \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e details to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e, you must submit information on the UK \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e and the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e location of the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e to the Article 57 database in accordance with Regulation (EC) No 726/2004 Article 57(2).\u003c/p\u003e\n\n\u003ch3 id=\"webinar-recordings\"\u003e6.1 Webinar recordings\u003c/h3\u003e\n\n\u003cp\u003eThe following webinar recordings on pharmacovigilance requirements for UK authorised products webinars are available:\u003c/p\u003e\n\n\u003cp\u003eThis webinar was part of a series of Brexit and post-transition guidance webinars and took place on 13 January 2020:\u003c/p\u003e\n\n\u003cp\u003e\u003ca rel=\"external\" href=\"https://youtu.be/AGTitnGny50\" class=\"govuk-link\"\u003ePharmacovigilance requirements for UK authorised products webinar recording, which took place on 13 January 2020:\u003c/a\u003e\u003c/p\u003e\n\n\u003cp\u003ePost transition: Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 22 October 2020:\u003c/p\u003e\n\n\u003cp\u003e\u003ca rel=\"external\" href=\"https://youtu.be/I3CkPHWQI8M\" class=\"govuk-link\"\u003ePharmacovigilance requirements for UK authorised products webinar recording, which took place on 22 October 2020.\u003c/a\u003e\u003c/p\u003e\n\n\u003cp\u003eWindsor Framework webinar which took place on 19 September 2024:\u003c/p\u003e\n\n\u003cp\u003e\u003ca rel=\"external\" href=\"https://www.youtube.com/watch?v=q4Mp2H3PzZs\" class=\"govuk-link\"\u003eWindsor Framework webinar, 19 September 2024\u003c/a\u003e\u003c/p\u003e\n\n\u003ch2 id=\"contact\"\u003e7. Contact\u003c/h2\u003e\n\n\u003cp\u003eGeneral queries relating to the \u003cabbr title=\"qualified person responsible for pharmacovigilance\"\u003eQPPV\u003c/abbr\u003e, \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e and establishment of pharmacovigilance systems for UK authorised products should be sent to \u003ca href=\"mailto:gpvpinspectors@mhra.gov.uk\" class=\"govuk-link\"\u003egpvpinspectors@mhra.gov.uk\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eQueries relating to the UK \u003cabbr title=\"pharmacovigilance system master file\"\u003ePSMF\u003c/abbr\u003e number should be sent to \u003ca href=\"mailto:UKPSMFadmin@mhra.gov.uk\" class=\"govuk-link\"\u003eUKPSMFadmin@mhra.gov.uk\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eQueries relating to submission of Type IA variations should be sent to \u003ca href=\"mailto:variationqueries@mhra.gov.uk\" class=\"govuk-link\"\u003evariationqueries@mhra.gov.uk\u003c/a\u003e\u003c/p\u003e\n\n\u003cp\u003eFor further information, please email our Customer Services Centre at \u003ca href=\"mailto:info@mhra.gov.uk\" class=\"govuk-link\"\u003einfo@mhra.gov.uk\u003c/a\u003e or call 020 3080 6000. You can also email \u003ca href=\"mailto:vigilanceservice@mhra.gov.uk\" class=\"govuk-link\"\u003evigilanceservice@mhra.gov.uk\u003c/a\u003e with urgent questions. Alternatively, contact your Trade Association.\u003c/p\u003e\n\n\u003c/div\u003e",
                    "change_history":  [
                                           {
                                               "note":  "· Updates made to indicate requirements for Category 1 and Category 2 products following the implementation of the Windsor Framework.\r\n· PSMF accessibility – Sentence added to state that PSMF must be up to date at the point it is sent to the licensing authority.",
                                               "public_timestamp":  "2025-01-08T16:31:15.000+00:00"
                                           },
                                           {
                                               "note":  "Updated guidance which replaces the previous requirement to submit a Type IA(IN) variation and an accompanying eCTD sequence following updates to the UK PSMF and UK QPPV information.",
                                               "public_timestamp":  "2023-11-17T16:53:00.000+00:00"
                                           },
                                           {
                                               "note":  "New guidance has replaced the previous section; \u0027Notification of QPPV and PSMF details to\r\nthe MHRA by existing holders of UK marketing authorisations\u0027. This guidance replaces the previous requirement to submit a Type IA(IN) variation and an accompanying eCTD sequence to make these changes. This has been simplified and only an update notification is required, there is no requirement to submit an eCTD sequence. ",
                                               "public_timestamp":  "2023-05-11T15:06:48.000+01:00"
                                           },
                                           {
                                               "note":  "Additional guidance on requesting a UK PSMF number has been added.",
                                               "public_timestamp":  "2021-11-30T14:47:50.000+00:00"
                                           },
                                           {
                                               "note":  "Following user feedback, we have edited some of this guidance to make it easier to understand and clarified certain points. ",
                                               "public_timestamp":  "2021-02-01T16:36:32.000+00:00"
                                           },
                                           {
                                               "note":  "New video entry - Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 13 January 2020",
                                               "public_timestamp":  "2021-01-29T12:30:39.000+00:00"
                                           },
                                           {
                                               "note":  "First published.",
                                               "public_timestamp":  "2020-12-31T00:00:00.000+00:00"
                                           }
                                       ],
                    "emphasised_organisations":  [
                                                     "240f72bd-9a4d-4f39-94d9-77235cadde8e"
                                                 ],
                    "first_public_at":  "2020-12-31T00:00:00.000+00:00",
                    "political":  false,
                    "related_mainstream_content":  [

                                                   ],
                    "tags":  {
                                 "browse_pages":  [

                                                  ]
                             }
                },
    "document_type":  "detailed_guide",
    "first_published_at":  "2020-12-31T00:00:00+00:00",
    "links":  {
                  "available_translations":  [
                                                 {
                                                     "api_path":  "/api/content/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
                                                     "api_url":  "https://www.gov.uk/api/content/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
                                                     "base_path":  "/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
                                                     "content_id":  "d3fe78e6-f1f5-48ff-acc9-5148331aa132",
                                                     "document_type":  "detailed_guide",
                                                     "links":  {

                                                               },
                                                     "locale":  "en",
                                                     "public_updated_at":  "2025-01-08T16:31:15Z",
                                                     "schema_name":  "detailed_guide",
                                                     "title":  "Guidance on qualified person responsible for pharmacovigilance (QPPV) including pharmacovigilance system master files (PSMF)",
                                                     "web_url":  "https://www.gov.uk/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
                                                     "withdrawn":  false
                                                 }
                                             ],
                  "document_collections":  [
                                               {
                                                   "api_path":  "/api/content/government/collections/new-guidance-and-information-for-industry-from-the-mhra",
                                                   "api_url":  "https://www.gov.uk/api/content/government/collections/new-guidance-and-information-for-industry-from-the-mhra",
                                                   "base_path":  "/government/collections/new-guidance-and-information-for-industry-from-the-mhra",
                                                   "content_id":  "aecc31f9-1d53-4c18-9df4-4e5940323c4f",
                                                   "document_type":  "document_collection",
                                                   "links":  {
                                                                 "documents":  [
                                                                                   {
                                                                                       "api_path":  "/api/content/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
                                                                                       "api_url":  "https://www.gov.uk/api/content/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
                                                                                       "base_path":  "/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
                                                                                       "content_id":  "d3fe78e6-f1f5-48ff-acc9-5148331aa132",
                                                                                       "document_type":  "detailed_guide",
                                                                                       "links":  {

                                                                                                 },
                                                                                       "locale":  "en",
                                                                                       "public_updated_at":  "2025-01-08T16:31:15Z",
                                                                                       "schema_name":  "detailed_guide",
                                                                                       "title":  "Guidance on qualified person responsible for pharmacovigilance (QPPV) including pharmacovigilance system master files (PSMF)",
                                                                                       "web_url":  "https://www.gov.uk/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
                                                                                       "withdrawn":  false
                                                                                   }
                                                                               ]
                                                             },
                                                   "locale":  "en",
                                                   "public_updated_at":  "2021-03-30T10:06:39Z",
                                                   "schema_name":  "document_collection",
                                                   "title":  "New guidance and information for industry from the MHRA",
                                                   "web_url":  "https://www.gov.uk/government/collections/new-guidance-and-information-for-industry-from-the-mhra",
                                                   "withdrawn":  false
                                               },
                                               {
                                                   "api_path":  "/api/content/government/collections/moving-goods-into-out-of-or-through-northern-ireland",
                                                   "api_url":  "https://www.gov.uk/api/content/government/collections/moving-goods-into-out-of-or-through-northern-ireland",
                                                   "base_path":  "/government/collections/moving-goods-into-out-of-or-through-northern-ireland",
                                                   "content_id":  "a3deaf0f-3161-40a1-b122-02d016fcb526",
                                                   "document_type":  "document_collection",
                                                   "links":  {
                                                                 "documents":  [
                                                                                   {
                                                                                       "api_path":  "/api/content/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
                                                                                       "api_url":  "https://www.gov.uk/api/content/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
                                                                                       "base_path":  "/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
                                                                                       "content_id":  "d3fe78e6-f1f5-48ff-acc9-5148331aa132",
                                                                                       "document_type":  "detailed_guide",
                                                                                       "links":  {

                                                                                                 },
                                                                                       "locale":  "en",
                                                                                       "public_updated_at":  "2025-01-08T16:31:15Z",
                                                                                       "schema_name":  "detailed_guide",
                                                                                       "title":  "Guidance on qualified person responsible for pharmacovigilance (QPPV) including pharmacovigilance system master files (PSMF)",
                                                                                       "web_url":  "https://www.gov.uk/guidance/guidance-on-qualified-person-responsible-for-pharmacovigilance-qppv-including-pharmacovigilance-system-master-files-psmf",
                                                                                       "withdrawn":  false
                                                                                   }
                                                                               ]
                                                             },
                                                   "locale":  "en",
                                                   "public_updated_at":  "2021-01-07T00:00:00Z",
                                                   "schema_name":  "document_collection",
                                                   "title":  "Moving goods into, out of, or through Northern Ireland",
                                                   "web_url":  "https://www.gov.uk/government/collections/moving-goods-into-out-of-or-through-northern-ireland",
                                                   "withdrawn":  false
                                               }
                                           ],
                  "government":  [
                                     {
                                         "api_path":  "/api/content/government/2019-to-2022-johnson-conservative-government",
                                         "api_url":  "https://www.gov.uk/api/content/government/2019-to-2022-johnson-conservative-government",
                                         "base_path":  "/government/2019-to-2022-johnson-conservative-government",
                                         "content_id":  "4ed901ec-c8ce-42d5-a2aa-6d7f462480df",
                                         "details":  {
                                                         "current":  false,
                                                         "ended_on":  "2022-09-06T00:00:00+00:00",
                                                         "started_on":  "2019-07-24T00:00:00+00:00"
                                                     },
                                         "document_type":  "government",
                                         "links":  {

                                                   },
                                         "locale":  "en",
                                         "title":  "2019 to 2022 Johnson Conservative government",
                                         "web_url":  "https://www.gov.uk/government/2019-to-2022-johnson-conservative-government"
                                     }
                                 ],
                  "organisations":  [
                                        {
                                            "analytics_identifier":  "EA63",
                                            "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                            "details":  {
                                                            "acronym":  "MHRA",
                                                            "brand":  "department-of-health",
                                                            "default_news_image":  null,
                                                            "logo":  {
                                                                         "crest":  "single-identity",
                                                                         "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                     },
                                                            "organisation_govuk_status":  {
                                                                                              "status":  "live",
                                                                                              "updated_at":  null,
                                                                                              "url":  null
                                                                                          }
                                                        },
                                            "document_type":  "organisation",
                                            "links":  {

                                                      },
                                            "locale":  "en",
                                            "schema_name":  "organisation",
                                            "title":  "Medicines and Healthcare products Regulatory Agency",
                                            "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "withdrawn":  false
                                        }
                                    ],
                  "original_primary_publishing_organisation":  [
                                                                   {
                                                                       "analytics_identifier":  "EA63",
                                                                       "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                                       "details":  {
                                                                                       "acronym":  "MHRA",
                                                                                       "brand":  "department-of-health",
                                                                                       "default_news_image":  null,
                                                                                       "logo":  {
                                                                                                    "crest":  "single-identity",
                                                                                                    "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                                },
                                                                                       "organisation_govuk_status":  {
                                                                                                                         "status":  "live",
                                                                                                                         "updated_at":  null,
                                                                                                                         "url":  null
                                                                                                                     }
                                                                                   },
                                                                       "document_type":  "organisation",
                                                                       "links":  {

                                                                                 },
                                                                       "locale":  "en",
                                                                       "schema_name":  "organisation",
                                                                       "title":  "Medicines and Healthcare products Regulatory Agency",
                                                                       "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "withdrawn":  false
                                                                   }
                                                               ],
                  "primary_publishing_organisation":  [
                                                          {
                                                              "analytics_identifier":  "EA63",
                                                              "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                              "details":  {
                                                                              "acronym":  "MHRA",
                                                                              "brand":  "department-of-health",
                                                                              "default_news_image":  null,
                                                                              "logo":  {
                                                                                           "crest":  "single-identity",
                                                                                           "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                       },
                                                                              "organisation_govuk_status":  {
                                                                                                                "status":  "live",
                                                                                                                "updated_at":  null,
                                                                                                                "url":  null
                                                                                                            }
                                                                          },
                                                              "document_type":  "organisation",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "schema_name":  "organisation",
                                                              "title":  "Medicines and Healthcare products Regulatory Agency",
                                                              "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "suggested_ordered_related_items":  [
                                                          {
                                                              "api_path":  "/api/content/guidance/guidance-on-mah-and-qppv-location",
                                                              "api_url":  "https://www.gov.uk/api/content/guidance/guidance-on-mah-and-qppv-location",
                                                              "base_path":  "/guidance/guidance-on-mah-and-qppv-location",
                                                              "content_id":  "db1dcc27-0f12-47c2-bfaf-466737a5d608",
                                                              "document_type":  "detailed_guide",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2025-01-08T16:31:09Z",
                                                              "schema_name":  "detailed_guide",
                                                              "title":  "Guidance on MAH and QPPV location",
                                                              "web_url":  "https://www.gov.uk/guidance/guidance-on-mah-and-qppv-location",
                                                              "withdrawn":  false
                                                          },
                                                          {
                                                              "api_path":  "/api/content/government/publications/exceptions-and-modifications-to-the-eu-guidance-on-good-pharmacovigilance-practices-that-will-apply-to-uk-mahs-and-the-mhra",
                                                              "api_url":  "https://www.gov.uk/api/content/government/publications/exceptions-and-modifications-to-the-eu-guidance-on-good-pharmacovigilance-practices-that-will-apply-to-uk-mahs-and-the-mhra",
                                                              "base_path":  "/government/publications/exceptions-and-modifications-to-the-eu-guidance-on-good-pharmacovigilance-practices-that-will-apply-to-uk-mahs-and-the-mhra",
                                                              "content_id":  "79cb8f46-8cda-46a3-a73f-ef254ee427ea",
                                                              "document_type":  "guidance",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2024-12-30T12:32:12Z",
                                                              "schema_name":  "publication",
                                                              "title":  "Exceptions and modifications to the EU guidance on good pharmacovigilance practices that apply to UK MAHs and the MHRA",
                                                              "web_url":  "https://www.gov.uk/government/publications/exceptions-and-modifications-to-the-eu-guidance-on-good-pharmacovigilance-practices-that-will-apply-to-uk-mahs-and-the-mhra",
                                                              "withdrawn":  false
                                                          },
                                                          {
                                                              "api_path":  "/api/content/government/publications/guidance-on-pharmacovigilance-procedures",
                                                              "api_url":  "https://www.gov.uk/api/content/government/publications/guidance-on-pharmacovigilance-procedures",
                                                              "base_path":  "/government/publications/guidance-on-pharmacovigilance-procedures",
                                                              "content_id":  "e907abe9-266d-4fa5-8ff6-9b91b2791cdc",
                                                              "document_type":  "guidance",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2025-01-08T16:31:04Z",
                                                              "schema_name":  "publication",
                                                              "title":  "Guidance on pharmacovigilance procedures",
                                                              "web_url":  "https://www.gov.uk/government/publications/guidance-on-pharmacovigilance-procedures",
                                                              "withdrawn":  false
                                                          },
                                                          {
                                                              "api_path":  "/api/content/government/collections/good-pharmacovigilance-practice-for-medicines-gpvp",
                                                              "api_url":  "https://www.gov.uk/api/content/government/collections/good-pharmacovigilance-practice-for-medicines-gpvp",
                                                              "base_path":  "/government/collections/good-pharmacovigilance-practice-for-medicines-gpvp",
                                                              "content_id":  "57b67b41-32e1-49df-be97-9727d3ccfb6d",
                                                              "document_type":  "document_collection",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2014-12-18T18:23:00Z",
                                                              "schema_name":  "document_collection",
                                                              "title":  "Good pharmacovigilance practice for medicines (GPvP)",
                                                              "web_url":  "https://www.gov.uk/government/collections/good-pharmacovigilance-practice-for-medicines-gpvp",
                                                              "withdrawn":  false
                                                          },
                                                          {
                                                              "api_path":  "/api/content/government/statistics/pharmacovigilance-inspection-metrics-2009-to-present",
                                                              "api_url":  "https://www.gov.uk/api/content/government/statistics/pharmacovigilance-inspection-metrics-2009-to-present",
                                                              "base_path":  "/government/statistics/pharmacovigilance-inspection-metrics-2009-to-present",
                                                              "content_id":  "5ef066eb-7631-11e4-a3cb-005056011aef",
                                                              "document_type":  "official_statistics",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2023-09-01T10:02:39Z",
                                                              "schema_name":  "publication",
                                                              "title":  "Pharmacovigilance inspection metrics, 2009 to present",
                                                              "web_url":  "https://www.gov.uk/government/statistics/pharmacovigilance-inspection-metrics-2009-to-present",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "taxons":  [
                                 {
                                     "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood-good-practice",
                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood-good-practice",
                                     "base_path":  "/health-and-social-care/medicines-medical-devices-blood-good-practice",
                                     "content_id":  "326e92c5-253d-4ab9-bdef-bffa0985fa7b",
                                     "details":  {
                                                     "internal_name":  "Good practice, inspections and enforcement [T]",
                                                     "notes_for_editors":  "",
                                                     "visible_to_departmental_editors":  false
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "base_path":  "/health-and-social-care/medicines-medical-devices-blood",
                                                                             "content_id":  "cebc01ee-f70a-4397-a552-622e10b62508",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Medicines and medical devices [T] (level 2, health theme)",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  false
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "parent_taxons":  [
                                                                                                                 {
                                                                                                                     "api_path":  "/api/content/health-and-social-care",
                                                                                                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care",
                                                                                                                     "base_path":  "/health-and-social-care",
                                                                                                                     "content_id":  "8124ead8-8ebc-4faf-88ad-dd5cbcc92ba8",
                                                                                                                     "description":  "",
                                                                                                                     "details":  {
                                                                                                                                     "internal_name":  "Health and social care",
                                                                                                                                     "notes_for_editors":  "",
                                                                                                                                     "visible_to_departmental_editors":  true
                                                                                                                                 },
                                                                                                                     "document_type":  "taxon",
                                                                                                                     "links":  {
                                                                                                                                   "root_taxon":  ""
                                                                                                                               },
                                                                                                                     "locale":  "en",
                                                                                                                     "phase":  "live",
                                                                                                                     "public_updated_at":  "2018-09-16T20:30:51Z",
                                                                                                                     "schema_name":  "taxon",
                                                                                                                     "title":  "Health and social care",
                                                                                                                     "web_url":  "https://www.gov.uk/health-and-social-care",
                                                                                                                     "withdrawn":  false
                                                                                                                 }
                                                                                                             ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2019-02-06T16:16:55Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Medicines, medical devices",
                                                                             "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2018-08-22T12:56:21Z",
                                     "schema_name":  "taxon",
                                     "title":  "Good practice, inspections and enforcement",
                                     "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood-good-practice",
                                     "withdrawn":  false
                                 },
                                 {
                                     "api_path":  "/api/content/government/brexit",
                                     "api_url":  "https://www.gov.uk/api/content/government/brexit",
                                     "base_path":  "/government/brexit",
                                     "content_id":  "d6c2de5d-ef90-45d1-82d4-5f2438369eea",
                                     "description":  "Find out how new Brexit rules apply to things like travel and doing business with Europe.",
                                     "details":  {
                                                     "internal_name":  "Brexit",
                                                     "notes_for_editors":  "",
                                                     "url_override":  "/government/collections/brexit-guidance",
                                                     "visible_to_departmental_editors":  true
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/government/all",
                                                                             "api_url":  "https://www.gov.uk/api/content/government/all",
                                                                             "base_path":  "/government/all",
                                                                             "content_id":  "e48ab80a-de80-4e83-bf59-26316856a5f9",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Government",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  true
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "root_taxon":  [
                                                                                                              {
                                                                                                                  "api_path":  "/api/content/",
                                                                                                                  "api_url":  "https://www.gov.uk/api/content/",
                                                                                                                  "base_path":  "/",
                                                                                                                  "content_id":  "f3bbdec2-0e62-4520-a7fd-6ffd5d36e03a",
                                                                                                                  "document_type":  "homepage",
                                                                                                                  "links":  {

                                                                                                                            },
                                                                                                                  "locale":  "en",
                                                                                                                  "public_updated_at":  "2023-06-28T09:32:34Z",
                                                                                                                  "schema_name":  "homepage",
                                                                                                                  "title":  "GOV.UK homepage",
                                                                                                                  "web_url":  "https://www.gov.uk/",
                                                                                                                  "withdrawn":  false
                                                                                                              }
                                                                                                          ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2018-09-16T20:29:39Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Government",
                                                                             "web_url":  "https://www.gov.uk/government/all",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2024-11-14T17:47:34Z",
                                     "schema_name":  "taxon",
                                     "title":  "Brexit",
                                     "web_url":  "https://www.gov.uk/government/brexit",
                                     "withdrawn":  false
                                 }
                             ]
              },
    "locale":  "en",
    "phase":  "live",
    "public_updated_at":  "2025-01-08T16:31:15+00:00",
    "publishing_app":  "whitehall",
    "publishing_request_id":  "21-1736353875.455-10.13.21.43-2850",
    "publishing_scheduled_at":  "2020-12-31T23:00:00+00:00",
    "rendering_app":  "government-frontend",
    "scheduled_publishing_delay_seconds":  172,
    "schema_name":  "detailed_guide",
    "title":  "Guidance on qualified person responsible for pharmacovigilance (QPPV) including pharmacovigilance system master files (PSMF)",
    "updated_at":  "2025-01-08T16:31:15+00:00",
    "withdrawn_notice":  {

                         }
}
